Natco Pharma - Enough Correction

523
CMP 875 on 22.05.25
The stock price dropped 50% between September 2024 and March 2025. In recent days, it has been consolidating near the 800 levels, which is acting as a support zone, as shown on the chart.
MACD shows a likely crossover, too.
If it gives an upside move, further targets may be 1080/1180 or more.
One has to keep the position size according to the risk management.
The setup will go weak if it sustains below 800-775 levels.
All these illustrations are only for learning and sharing purposes, not a piece of trading advice in any way.
All the best.

Penafian

Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.